Complement regulatory molecules: application to therapy and transplantation.
Morgan
B P
BP
Dept of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, UK.
D000818:Animals; D030801:Animals, Genetically Modified; D015703:Antigens, CD / Q000235:genetics / Q000627:therapeutic use; D018958:CD55 Antigens; D018957:CD59 Antigens; D003167:Complement Activation / Q000187:drug effects*; D003165:Complement System Proteins / Q000502:physiology*; D015195:Drug Design; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000235:genetics / Q000627:therapeutic use; D010215:Papio; D017463:Receptors, Complement 3b / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013552:Swine; D014181:Transplantation Immunology / Q000187:drug effects; D014183:Transplantation, Heterologous
D015703:Antigens, CD; C497857:CD46 protein, human; D018958:CD55 Antigens; D018957:CD59 Antigens; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D017463:Receptors, Complement 3b; D011993:Recombinant Fusion Proteins; D003165:Complement System Proteins